Specialists in the Women's Lung Cancer Program have provided answers to many commonly asked questions about women and lung cancer.
Studies suggest that there are differences in the way lung cancer develops among men and women. Some of these findings include:
While breast cancer is diagnosed twice as often as lung cancer, lung cancer accounts for more deaths among women each year than breast, ovarian, and uterine cancers combined.
Risk factors for lung cancer include:
Many patients with early lung cancer do not experience symptoms, or symptoms are attributed to other medical conditions. The following symptoms are common in patients with advanced lung cancer:
Lung cancer can be difficult to diagnose, and often numerous tests, including imaging studies and biopsies, are needed to determine an accurate diagnosis. Common tests include:
Imaging – Imaging provides pictures of tumors and disease activity and is non-invasive or involves only an injection.
Surgical biopsy – A surgical biopsy is used for conclusive diagnosis. Biopsies can be performed a number of ways:
Lung cancers, like many other cancers, often require treatment using multiple approaches – including surgery, radiation, and medical therapies.
To learn more about treatment for lung cancer, please click here.
For more information about clinical trials, please click here.
Researchers in our Program are evaluating better ways to stage lung cancer and prevent lung cancer from recurring. We also continue to look at genetic clues to susceptibility to lung cancer and severity of the disease, as well as how that information can help in each patient’s care.
For more information regarding research in the Women’s Lung Cancer Program, please click here.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.